The drug price negotiation provisions in the Inflation Reduction Act were designed to continue evolving with each passing year. As CMS prepares for 2028 and 2029, the agency has put out new draft ...

Anti-OX40L antibody amlitelimab was discarded as a treatment for atopic dermatitis last week, and today – during its ...

According to a letter (PDF) signed by US Senators Elizabeth Warren (D-Mass), Angela Alsobrooks (D-Md), Richard Blumenthal ...

Texas Attorney General Ken Paxton has filed a lawsuit against Sanofi, claiming the company bribed doctors to prescribe its medicines, in the state's latest broadside against pharma groups. The ...

Cytokinetics is one of the first drugmakers to benefit from the UK's dual regulatory and reimbursement appraisals, getting a ...

FDA advisors have voted that Capricor Therapeutics has not provided strong evidence of efficacy for its cell therapy for ...

For most of biopharma's history, organisations treated this kind of reasoning as something that would transfer on its own ...

AbbVie's fast-growing JAK inhibitor Rinvoq has been cleared for alopecia areata in the EU, the first market for the hair loss ...

As a result, professionals responsible for lab operations, facilities, engineering, and asset management are taking on a more strategic role in supporting scientific excellence while driving ...

Moreover, there are blood tests based on biomarkers that measure the body's immune response to infection, such as the Qiagen ...

A US judge has ordered that Novo Nordisk must face some allegations in court that it defrauded investors by making misleading ...

Shrugging off an earlier phase 3 disappointment, Travere’s Filspari has become the first FDA-approved treatment for rare kidney disease focal segmental glomerulosclerosis (FSGS). The company's already ...